Literature DB >> 23427097

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism.

Lloyd A Demetrius1, David K Simon.   

Abstract

The sporadic forms of cancer and Alzheimer's disease (AD) are both age-related metabolic disorders. However, the molecular mechanisms underlying the two diseases are distinct: cancer is described by essentially limitless replicative potential, whereas neuronal death is a key feature of AD. Studies of the origin of both diseases indicate that their sporadic forms are the result of metabolic dysregulation, and a compensatory increase in energy transduction that is inversely related. In cancer, the compensatory metabolic effect is the upregulation of glycolysis-the Warburg effect; in AD, a bioenergetic model based on the interaction between astrocytes and neurons indicates that the compensatory metabolic alteration is the upregulation of oxidative phosphorylation-an inverse Warburg effect. These two modes of metabolic alteration could contribute to an inverse relation between the incidence of the two diseases. We invoke this bioenergetic mechanism to furnish a molecular basis for an epidemiological observation, namely the incidence of sporadic forms of cancer and AD is inversely related. We furthermore exploit the molecular mechanisms underlying the diseases to propose common therapeutic strategies for cancer and AD based on metabolic intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23427097      PMCID: PMC3627084          DOI: 10.1098/rsif.2013.0006

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  34 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 3.  Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease.

Authors:  Xiongwei Zhu; George Perry; Paula I Moreira; Gjumrakch Aliev; Adam D Cash; Keisuke Hirai; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

4.  The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.

Authors:  Angel Herrero-Mendez; Angeles Almeida; Emilio Fernández; Carolina Maestre; Salvador Moncada; Juan P Bolaños
Journal:  Nat Cell Biol       Date:  2009-05-17       Impact factor: 28.824

5.  Quantum metabolism explains the allometric scaling of metabolic rates.

Authors:  Lloyd Demetrius; J A Tuszynski
Journal:  J R Soc Interface       Date:  2009-09-04       Impact factor: 4.118

Review 6.  Directionality principles in thermodynamics and evolution.

Authors:  L Demetrius
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 7.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

8.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

Review 9.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

10.  Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons.

Authors:  Jack H Jhamandas; David MacTavish
Journal:  J Neurosci       Date:  2004-06-16       Impact factor: 6.167

View more
  20 in total

1.  Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity.

Authors:  Wen Fu; Diya Shi; David Westaway; Jack H Jhamandas
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

Review 2.  Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review.

Authors:  Shantell C Nolen; Marcella A Evans; Avital Fischer; Maria M Corrada; Claudia H Kawas; Daniela A Bota
Journal:  Mech Ageing Dev       Date:  2017-05-11       Impact factor: 5.432

Review 3.  Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?

Authors:  Juan F Codocedo; Juvenal A Ríos; Juan A Godoy; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

Review 4.  Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.

Authors:  Cristina Lanni; Mirco Masi; Marco Racchi; Stefano Govoni
Journal:  Mol Psychiatry       Date:  2020-05-07       Impact factor: 15.992

5.  Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics.

Authors:  Yen-Chen Anne Feng; Kelly Cho; Sara Lindstrom; Peter Kraft; Jean Cormack; Liming Liang; Jane A Driver
Journal:  Hum Genet       Date:  2017-08-05       Impact factor: 4.132

Review 6.  Preventing Alzheimer's disease by means of natural selection.

Authors:  Lloyd A Demetrius; Jane A Driver
Journal:  J R Soc Interface       Date:  2015-01-06       Impact factor: 4.118

Review 7.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

8.  Is Cancer Protective for Subsequent Alzheimer's Disease Risk? Evidence From the Utah Population Database.

Authors:  Heidi A Hanson; Kevin P Horn; Kelli M Rasmussen; John M Hoffman; Ken R Smith
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2017-10-01       Impact factor: 4.077

Review 9.  Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunology.

Authors:  Bernard J Crespi; Matthew C Go
Journal:  Evol Med Public Health       Date:  2015-09-09

10.  Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer's disease.

Authors:  Anatoly Mayburd; Ancha Baranova
Journal:  BMC Syst Biol       Date:  2013-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.